Publication | Open Access
Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer
79
Citations
59
References
2018
Year
OncologyHealth SciencesMedicinePharmacologyImmune Checkpoint InhibitorBreast CancerAnti-cancer AgentCancer TreatmentCancer BiologyCell BiologyCancer ResearchCancer Stem CellsDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1